Home » Topics » Science » New compound

New compound
RSS

New small molecule VMY- BC-1 shows promise in vitro for TNBC

Dec. 20, 2019

KIN-8194 overcomes BTK C481S-mediated ibrutinib resistance in preclinical models

Dec. 18, 2019

First phase III data for YF-H-2015005 shows rapid mobilization of CD34+ cells

Dec. 13, 2019

Novel FVIII mimetic bispecific antibody Mim8 exhibits preclinical efficacy against hemophilia A

Dec. 12, 2019

Discovery and preclinical characterization of novel DHODH inhibitors for AML

Dec. 12, 2019

CYT-0853 demonstrates promising activity in models of autoimmune disease

Dec. 12, 2019

VRG-50014 rescues ALS phenotypes in preclinical models

Dec. 12, 2019

MAC-545496, a potent inhibitor that attenuates virulence and reverses antibiotic resistance in MRSA

Dec. 4, 2019

GSK-3527497, a new preclinical candidate for effective inhibition of TRPV4

Nov. 29, 2019

ALG-055009: a THR-beta agonist for treating NASH

Nov. 22, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...